Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | XPO1 | O14980 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | GSK3B | P49841 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5307393 | 1.00 | PTPN1 (0.40) | PTPN1HTTPOLBKDM4ELMNA | |
| SCHEMBL4926758 | 1.00 | PTPN1 (0.40) | PTPN1HTTPOLBKDM4ELMNA | |
| SCHEMBL13496330 | 0.82 | PTPN1 (0.36) | PTPN1HTTKDM4ELMNAMAPT | |
| SCHEMBL76528 | 0.82 | ALDH1A1 (0.39) | PTPN1HTTPOLBKDM4ELMNA | |
| SCHEMBL26300297 | 0.81 | CYP1A2 (0.39) | POLBCHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL16691271 | 0.81 | PTPN1 (0.38) | PTPN1HTTKDM4ELMNAMAPT | |
| SCHEMBL15216845 | 0.81 | PTPN1 (0.38) | PTPN1HTTKDM4ELMNAMAPT | |
| SCHEMBL5898372 | 0.80 | PTPN1 (0.40) | PTPN1HTTKDM4ELMNAMAPT | |
| SCHEMBL5898366 | 0.80 | PTPN1 (0.40) | PTPN1HTTKDM4ELMNAMAPT | |
| SCHEMBL9925264 | 0.79 | PTPN1 (0.37) | PTPN1HTTKDM4ELMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7390825-B1 | Process for the preparation of oxazolidinones and method of use thereof | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2008-06-24 | — | — | US | disclosed |
| US-20080146458-A1 | PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2008-06-19 | — | — | US | disclosed |
| US-20070265451-A1 | Process for the preparation of oxazolidinones and method of use thereof | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2007-11-15 | — | — | US | disclosed |
| WO-2007035066-A1 | THE METHOD OF MAKING OPTICALLY ACTIVE 3-ACYLOXY-GAMMA-BUTYROLACTONE AND OPTICALLY ACTIVE 3-HYDROXY-GAMMA-BUTYROLACTONE BY ENZYMATIC METHOD | ENZYTECH, LTD. (KR) | 2007-03-29 | — | — | WO | disclosed |
| EP-1578723-A4 | PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF | UNIV MICHIGAN STATE (US) | 2006-11-02 | — | — | EP | disclosed |
| EP-1578723-A3 | PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF | MICHIGAN STATE UNIVERSITY (US) | 2005-10-20 | — | — | EP | disclosed |
| EP-1578723-A2 | PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF | MICHIGAN STATE UNIVERSITY (US) | 2005-09-28 | — | — | EP | disclosed |
| US-6713290-B2 | GENERATING PREFERENTIAL PARTICLE; INCUBATE STARCH AND OLIGOSACCHARIDE, OXIDIZE MIXTURE, CYCLIZE MIXTURE, RECOVER PREFERENTIAL COMPOUND | SAMSUNG FINE CHEMICALS CO., LTD. (KR) | 2004-03-30 | — | — | US | disclosed |
| CN-1483730-A | 'Beta'-substituted-'gamma'-butyrolactone | 鱼洪善 | 2004-03-24 | — | — | CN | disclosed |
| EP-1398312-A1 | Beta-substituted-gamma-butyrolactones and a process for preparation thereof | Uh, Hong-Sun (KR) | 2004-03-17 | — | — | EP | disclosed |
| EP-1100954-A1 | CONTINUOUS PROCESS FOR PREPARING OPTICALLY PURE (S)-3,4-DIHYDROXYBUTYRIC ACID DERIVATIVES | Samsung Fine Chemicals Co., Ltd. (KR) | 2001-05-23 | — | — | EP | disclosed |
| EP-1100953-A1 | CONTINUOUS PROCESS FOR PREPARING OPTICALLY PURE ($i(S))-3-HYDROXY-GAMA-BUTYROLACTONE | Samsung Fine Chemicals Co., Ltd. (KR) | 2001-05-23 | — | — | EP | disclosed |
| EP-1100948-A1 | PROCESS FOR PREPARING ALPHA-(1,4) LINKED OLIGOSACCHARIDE | Samsung Fine Chemicals Co., Ltd. (KR) | 2001-05-23 | — | — | EP | disclosed |
| US-6221639-B1 | FROM POLYSACCHARIDE SOURCE BY SELECTIVE ENZYMATIC DEGRATION OF AMYLOPECTIN TO ALPHA-(1,4) LINKED OLIGOSACCHARIDE; AND OXIDATION IN BASE AND SUBSEQUENT ESTERIFICATION WITH AN ALCOHOL IN THE PRESENCE OF AN ACID CATALYST | SAMSUNG FINE CHEMICALS CO., LTD. (KR) | 2001-04-24 | — | — | US | disclosed |
| US-6124122-A | PREPARING ALPHA-(1,4) LINKED OLIGOSACCHARIDE WITH ADEQUATE SUGAR DISTRIBUTION BY REACTING AMYLOPECTIN EASILY AVAILABLE FROM NATURAL PRODUCT WITH ENZYME UNDER A SPECIFIC CONDITION AND PERFORMING OXIDATION, ESTERIFICATION AND CYCLIZATION | SAMSUNG FINE CHEMICALS CO., LTD. (KR) | 2000-09-26 | — | — | US | disclosed |
| WO-2000005399-A1 | PROCESS FOR PREPARING OPTICALLY PURE (S)-3-HYDROXY-GAMA-BUTYROLACTONE | SAMSUNG FINE CHEMICALS CO., LTD. (KR) | 2000-02-03 | — | — | WO | disclosed |
| WO-2000005401-A1 | CONTINUOUS PROCESS FOR PREPARING OPTICALLY PURE (S)-3-HYDROXY-GAMA-BUTYROLACTONE | SAMSUNG FINE CHEMICALS CO., LTD. (KR) | 2000-02-03 | — | — | WO | disclosed |
| WO-2000005398-A1 | PROCESS FOR PREPARING ALPHA-(1,4) LINKED OLIGOSACCHARIDE | SAMSUNG FINE CHEMICALS CO., LTD. (KR) | 2000-02-03 | — | — | WO | disclosed |
| WO-2000005402-A1 | CONTINUOUS PROCESS FOR PREPARING OPTICALLY PURE (S)-3,4-DIHYDROXYBUTYRIC ACID DERIVATIVES | SAMSUNG FINE CHEMICALS CO., LTD. (KR) | 2000-02-03 | — | — | WO | disclosed |
| WO-2000005400-A1 | PROCESS FOR PREPARING OPTICALLY PURE (S)-3,4-DIHYDROXYBUTYRIC ACID DERIVATIVES | SAMSUNG FINE CHEMICALS CO., LTD. (KR) | 2000-02-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070265451-A1 | Process for the preparation of oxazolidinones and method of use thereof | OXA1L, OTC, ODC1 | PTPN1 2342/4885HTT 4763/4885POLB 364/4885 |
| US-20080146458-A1 | PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF | OXA1L, OGFOD1, CYP51A1 | PTPN1 3805/4885HTT 4798/4885POLB 128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.